The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Reversal of Type 1 Hepatorenal Syndrome With the Administration of Midodrine and Octreotide
Open accessAbstract
The aim of the study was to verify the effects of the administration of an inhibitor of the release of endogenous vasodilators together with a vasoconstrictor agent in patients with hepatorenal syndrome (HRS). This new medical perspective was compared with a traditional medical approach for HRS, such as the infusion of nonpressor doses of dopamine to produce renal vasodilation. Thirteen patients with type 1 HRS were enrolled in the study. Five of them were treated with the oral administration of midodrine and the parenteral administration of octreotide. In addition, the patients received 50 to 100 mL of 20% human albumin solution daily for 20 days. Midodrine and octreotide were dosed to obtain a stable increase of at least 15 mm Hg of mean arterial pressure. Eight patients were treated with the intravenous administration of nonpressor doses of dopamine (2–4 μg/kg/min) and the same daily amount of albumin. After 20 days of treatment with midodrine and octreotide, an impressive improvement in renal plasma flow (RPF), glomerular filtration rate, and urinary sodium excretion was observed in patients. This was accompanied by a significant reduction in plasma renin activity, plasma vasopressin, and plasma glucagon. No side effects were observed. Three patients were discharged from the hospital. One of them successfully underwent liver transplantation. One of the two remaining patients is still alive after 472 days with a preserved renal function, and the other died from terminal liver failure after 76 days. One of the two patients who were not discharged from the hospital successfully underwent liver transplantation, and the other died from pneumonia after 29 days. Seven out of eight patients who were treated with dopamine experienced a progressive deterioration in renal function and died during the first 12 days. Only one patient recovered renal function and underwent liver transplantation. In conclusion, the long–term administration of midodrine and octreotide seems to be an effective and safe treatment of type 1 HRS in patients with cirrhosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis†
Arroyo, V, Ginès, P., Gerbes, A. L., Dudley, F. J., Gentilini, P., Laffi, G., Reynolds, T. B., Ring-Larsen, H., & Schölmerich, J. (1996) · Hepatology · doi:10.1002/hep.510230122 · Cited by 1,703
Schrier, R. W., Arroyo, V., Bernardi, M., Epstein, M., Henriksen, J. H., & Rodés, J. (1988) · Hepatology · doi:10.1002/hep.1840080532 · Cited by 1,623
Lamberts, S. W. J., van der Lely, A.-J., de Herder, W. W., & Hofland, L. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340408 · Cited by 1,001
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites
Ginès, A., Escorsell, A., Ginès, P., Saló, J., Jiménez, W., Inglada, L., Navasa, M., Clària, J., Rimola, A., Arroyo, V., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90031-7 · Cited by 891
Guevara, M., Ginès, P., Fernández‐Esparrach, G., Sort, P., Salmerón, J. M., Jiménez, W., Arroyo, V., & Rodés, J. (1998) · Hepatology · doi:10.1002/hep.510270107 · Cited by 334
Planas, R., Bataller, R., & Rodés, J. (2000) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-000-0032-9 · Cited by 332
Plasma Endothelin Immunoreactivity in Liver Disease and the Hepatorenal Syndrome
Moore, K., Wendon, J., Frazer, M., Karani, J., Williams, R., & Badr, K. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212173272502 · Cited by 314
[Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome].
Møller, S., & Jh, H. (1993) · PubMed · Cited by 295
BOYER, T. D., ZIA, P. K., & Reynolds, T. B. (1979) · PubMed · Cited by 276
Sclerotherapy with or without Octreotide for Acute Variceal Bleeding
Besson, I., Ingrand, P., Person, B., Boutroux, D., Heresbach, D., Bernard, P., Hochain, P., Larricq, J., Gourlaouen, A., Ribard, D., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330904 · Cited by 274
Cited by
Human serum albumin: From bench to bedside
Fanali, G., di Masi, A., Trezza, V., Marino, M., Fasano, M., & Ascenzi, P. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.12.002 · Cited by 1,931
(2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.004 · Cited by 1,725
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis
Salerno, F., Gerbes, A., Ginès, P., Wong, F., & Arroyo, V. (2008) · Postgraduate Medical Journal · doi:10.1136/gut.2006.107789 · Cited by 1,081
Management of adult patients with ascites due to cirrhosis: An update†‡§
Runyon, B. A. (2009) · Hepatology · doi:10.1002/hep.22853 · Cited by 975
Lucey, M. R., Mathurin, P., & Morgan, T. R. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0805786 · Cited by 863
Ginès, P., & Schrier, R. W. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0809139 · Cited by 837
Management of Cirrhosis and Ascites
Ginès, P., Cárdenas, A., Arroyo, V., & Rodés, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035021 · Cited by 773
Mitzner, S. R., Stange, J., Klammt, S., Risler, T., Erley, C. M., Bader, B. D., Berger, E. D., Lauchart, W., Peszynski, P., Freytag, J., et al. (2000) · Liver Transplantation · doi:10.1002/lt.500060326 · Cited by 717
Acute kidney injury in cirrhosis
Garcia-Tsao, G., Parikh, C. R., & Viola, A. (2008) · Hepatology · doi:10.1002/hep.22605 · Cited by 662
Ortega, R. (2002) · Hepatology · doi:10.1016/s0270-9139(02)00101-5 · Cited by 602
Circulatory function and hepatorenal syndrome in cirrhosis†
Ruiz‐del‐Arbol, L., Monescillo, A., Arocena, C., Valer, P., Ginès, P., Moreira, V., María Milicua, J., Jiménez, W., & Arroyo, V. (2005) · Hepatology · doi:10.1002/hep.20766 · Cited by 592
Bacterial Infections, Sepsis, and Multiorgan Failure in Cirrhosis
Tandon, P., & Garcia-Tsao, G. (2008) · Seminars in Liver Disease · doi:10.1055/s-2008-1040319 · Cited by 551
Ginès, P., Guevara, M., Arroyo, V., & Rodés, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14903-3 · Cited by 517
Management of adult patients with ascites caused by cirrhosis†
Runyon, B. A. (1998) · Hepatology · doi:10.1002/hep.510270139 · Cited by 498
Garcia–Tsao, G. (2001) · Gastroenterology · doi:10.1053/gast.2001.22580 · Cited by 471
Angeli, P., Garcia-Tsao, G., Nadim, M. K., & Parikh, C. R. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.07.002 · Cited by 432
Self-citationWong, F., Pantea, L., & Sniderman, K. (2004) · Hepatology · doi:10.1002/hep.20262 · Cited by 395
Alessandria, C., Ozdogan, O., Guevara, M., Restuccia, T., Jiménez, W., Arroyo, V., Rodés, J., & Ginès, P. (2005) · Hepatology · doi:10.1002/hep.20687 · Cited by 372
Cavallin, M., Kamath, P. S., Merli, M., Fasolato, S., Toniutto, P., Salerno, F., Bernardi, M., Romanelli, R. G., Colletta, C., Salinas, F., et al. (2015) · Hepatology · doi:10.1002/hep.27709 · Cited by 359
Self-citationPortal Hypertension and Its Complications
Sanyal, A. J., Bosch, J., Blei, A., & Arroyo, V. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.007 · Cited by 358
Management of adult patients with ascites due to cirrhosis†
Runyon, B. A. (2004) · Hepatology · doi:10.1002/hep.20066 · Cited by 354
Treatment of Patients with Cirrhosis
Ge, P. S., & Runyon, B. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1504367 · Cited by 348
Alessandria, C., Ottobrelli, A., Debernardi-Venon, W., Todros, L., Cerenzia, M. T., Martini, S., Balzola, F., Morgando, A., Rizzetto, M., & Marzano, A. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.010 · Cited by 334
Planas, R., Bataller, R., & Rodés, J. (2000) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-000-0032-9 · Cited by 332
Brochard, L., Abroug, F., Brenner, M., Broccard, A. F., Danner, R. L., Ferrer, M., Laghi, F., Magder, S., Papazian, L., Pelosi, P., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1664st · Cited by 319
Update on Bispectral Index monitoring
Johansen, J. W. (2006) · Best Practice & Research Clinical Anaesthesiology · doi:10.1016/j.bpa.2005.08.004 · Cited by 313
SOLANKI, P., CHAWLA, A., GARG, R., GUPTA, R., JAIN, M., & SARIN, S. K. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.02934.x · Cited by 294
Acute-on-Chronic Liver Failure: Pathophysiological Basis of Therapeutic Options
Jalan, R., & Williams, R. (2002) · Blood Purification · doi:10.1159/000047017 · Cited by 286
Cirrhosis and its complications: Evidence based treatment
Nusrat, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i18.5442 · Cited by 285
Sharma, P., Kumar, A., Shrama, B. C., & Sarin, S. K. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01828.x · Cited by 281
Arroyo, V., & Colmenero, J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00007-2 · Cited by 279
Hepatorenal Syndrome: Pathophysiology and Management
Wadei, H. M., Mai, M. L., Ahsan, N., & Gonwa, T. A. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01340406 · Cited by 275
Acute renal failure in patients with cirrhosis: Perspectives in the age of MELD
Moreau, R., & Lebrec, D. (2003) · Hepatology · doi:10.1053/jhep.2003.50084 · Cited by 265
Ginès, P., Solà, E., Angeli, P., Wong, F., Nadim, M. K., & Kamath, P. S. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0022-7 · Cited by 260
Self-citationRomero, L. M., & Remage-Healey, L. (2000) · General and Comparative Endocrinology · doi:10.1006/gcen.2000.7491 · Cited by 259
Human albumin in the management of complications of liver cirrhosis
Bernardi, M., Maggioli, C., & Zaccherini, G. (2012) · Critical Care · doi:10.1186/cc11218 · Cited by 99
Metadata
- Authors
- Angeli, P., Volpin, R., Gerunda, G., Craighero, R., Roner, P., Merenda, R., Amodio, P., Sticca, A., Caregaro, L., Maffei-Faccioli, A., & Gatta, A.
- Venue
- Hepatology
- Published
- 1999-06
- Volume
- 29
- Issue
- 6
- Pages
- 1690-1697
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2011199481
- Cited by
- 564
- References
- 24
- FWCI
- 11.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.